Hedge Funds Aren’t Crazy About A. M. Castle & Co (CASL) Anymore

Seeing as A. M. Castle & Co (OTCMKTS:CASL) has experienced falling interest from the aggregate hedge fund industry, it’s easy to see that there lies a certain “tier” of funds who were dropping their positions entirely heading into Q4. Intriguingly, Andy Redleaf’s Whitebox Advisors dumped the biggest stake of all the investors followed by Insider Monkey, valued at an estimated $0.2 million in stock.

Let’s check out hedge fund activity in other stocks similar to A. M. Castle & Co (OTCMKTS:CASL). We will take a look at Xplore Technologies Corp. (NASDAQ:XPLR), Arca Biopharma Inc (NASDAQ:ABIO), Alliqua Biomedical Inc (NASDAQ:ALQA), and Identive Group, Inc. (NASDAQ:INVE). This group of stocks’ market values match CAS’s market value.

As you can see these stocks had an average of 3 hedge funds with bullish positions and the average amount invested in these stocks was $2 million. That figure was $11 million in CASL’s case. Arca Biopharma Inc (NASDAQ:ABIO) is the most popular stock in this table. On the other hand Xplore Technologies Corp. (NASDAQ:XPLR) is the least popular one with only 3 bullish hedge fund positions. Compared to these stocks A. M. Castle & Co (OTCMKTS:CASL) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.

Disclosure: None